Loading…
Identification of 14-3-3β in human gastric cancer cells and its potency as a diagnostic and prognostic biomarker
Gastric cancer is the second most common cause of cancer deaths worldwide and due to its poor prognosis, it is important that specific biomarkers are identified to enable its early detection. Through 2‐D gel electrophoresis and MALDI‐TOF‐TOF‐based proteomics approaches, we found that 14‐3‐3β, which...
Saved in:
Published in: | Proteomics (Weinheim) 2011-06, Vol.11 (12), p.2423-2439 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Gastric cancer is the second most common cause of cancer deaths worldwide and due to its poor prognosis, it is important that specific biomarkers are identified to enable its early detection. Through 2‐D gel electrophoresis and MALDI‐TOF‐TOF‐based proteomics approaches, we found that 14‐3‐3β, which was one of the proteins that were differentially expressed by 5‐fluorouracil‐treated gastric cancer SC‐M1 cells, was upregulated in gastric cancer cells. 14‐3‐3β levels in tissues and serum were further validated in gastric cancer patients and controls. The results showed that 14‐3‐3β levels were elevated in tumor tissues (n=40) in comparison to normal tissues (n=40; p |
---|---|
ISSN: | 1615-9853 1615-9861 |
DOI: | 10.1002/pmic.201000449 |